Epibrassinolide

2'-氟-2'-脱氧尿苷

4,6-Dichloro-2-(propylthio)-5-aminopyrimidine is a pharmaceutical intermediate that can be used as an intermediate for ticagrelor, an antithrombotic drug; it is a ticagrelor intermediate.

6-Bromo-2-chloro-8-cyclopentyl-5-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one is used for the preparation of pyrido[2,3-d]pyrimidin-7(8H)-one derivatives, such as CDK4 and/or CDK6 inhibitors. These derivatives can be used for disease treatment and are applicable in laboratory research and development processes,...

The mechanism of action of bazedoxifene acetate is unique. It is a novel selective estrogen receptor modulator (SERM) that selectively regulates estrogen receptors. Bazedoxifene acts as an estrogen receptor agonist in certain tissues of the body. In human bones, it has the same effect as estrogen (estrogen...

Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor.

Eldecalcitol is an active vitamin D3 derivative.

Eribulin mesylate is an antitumor drug used to treat patients with metastatic breast cancer.

Iriteacan mesylate 是一种 DNA 拓扑异构酶 I 抑制剂，IC50 值为 2.2 μM （0.975 μg/mL），可用于癌症研究。

Fmoc-3VVD-OH is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)

LCZ696 是美国 Novartis Pharmaceuticals 开发的一种心力衰竭治疗药物。心力衰竭是一种危及生命、使人衰弱的疾病，其中心脏无法泵出足够的血液来供应身体。呼吸急促、疲劳和体液潴留等症状可能会逐渐发展并随着时间的推移而恶化，从而严重影响生活质量。

The LCZ696 intermediate is an important organic synthesis and pharmaceutical research intermediate, primarily used for the synthesis of LCZ696 (Entresto). LCZ696 is a dual-acting angiotensin receptor neprilysin inhibitor (ARNI) composed of sacubitril and valsartan, and is widely used in the treatment of ca...

Val-cit-PAB-OH GMP is a GMP grade Val-cit-PAB-OH (HY-12362). Val-cit-PAB-OH is a degradable ADC linker.

ChemExpress have been shortlisted for Best CRO (Contract Research Organization) at the 11th World ADC Awards. 

Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.

ChemExpress have received EIR with the conclusion of the inspection, no FDA 483, Observations, was issued by US FDA on August 8th.

ChemExpress CDMO Services brochure (CDMO）

ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. 

ChemExpress ADC Products handbook (ADC)

ChemExpress FTE & FFS Services Flyer (FTE&FFS)

DMF Filed ADC Small Molecule Products